Tumor size reduction and serum CA 19-9 kinetics as metrics of resectability and response following neoadjuvant folfirinox in patients with pancreatic ductal adenocarcinoma

Autor: Servin-Rojas, M., Qiao, G., Ferrone, C.R., Fernandez-Del Castillo, C., Hang, L., Rocha-Castellanos, D., Fong, Z.V., Lillemoe, K.D., Qadan, M.
Zdroj: In HPB 2023 25 Supplement 1:S20-S21
Databáze: ScienceDirect